U S PHYSICAL THERAPY INC /NV (USPH) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 4.56M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 215.46M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 1.25B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $4.56M | $215.46M | (m) | (m) | $1.25B | (m) |
| 2026-03-31 | (m) | (m) | $10.80M | $194.04M | (m) | (m) | $1.24B | (m) |
| 2025-12-31 | (m) | (m) | $9.87M | $152.59M | (m) | (m) | $1.20B | (m) |
| 2025-09-30 | (m) | (m) | $8.80M | $151.46M | (m) | (m) | $1.20B | (m) |
| 2025-06-30 | (m) | (m) | $8.17M | $151.91M | (m) | (m) | $1.18B | (m) |
| 2025-03-31 | (m) | (m) | $9.26M | $157.24M | (m) | (m) | $1.18B | (m) |
| 2024-12-31 | (m) | (m) | $11.00M | $142.53M | (m) | (m) | $1.17B | (m) |
| 2024-09-30 | (m) | (m) | $9.61M | $132.92M | (m) | (m) | $1.03B | (m) |
| 2024-06-30 | (m) | (m) | $9.70M | $135.70M | (m) | (m) | $1.02B | (m) |
| 2024-03-31 | (m) | (m) | $9.22M | $136.75M | (m) | (m) | $1.02B | (m) |
| 2023-12-31 | (m) | (m) | $7.69M | $138.99M | (m) | (m) | $997.24M | (m) |
| 2023-09-30 | (m) | (m) | $7.55M | $141.50M | (m) | (m) | $1.01B | (m) |
| 2023-06-30 | (m) | (m) | $7.53M | $143.46M | (m) | (m) | $999.58M | (m) |
| 2023-03-31 | (m) | (m) | $7.73M | $182.68M | (m) | (m) | $868.13M | (m) |
| 2022-12-31 | (m) | (m) | $7.86M | $175.83M | (m) | (m) | $858.15M | (m) |
| 2022-09-30 | (m) | (m) | $7.49M | $146.69M | (m) | (m) | $799.71M | (m) |
| 2022-06-30 | (m) | (m) | $4.78M | $148.89M | (m) | (m) | $796.44M | (m) |
| 2022-03-31 | (m) | (m) | $799.00K | $122.13M | (m) | (m) | $763.86M | (m) |
| 2021-12-31 | (m) | (m) | $830.00K | $117.59M | (m) | (m) | $749.43M | (m) |
| 2021-09-30 | (m) | (m) | $672.00K | $35.27M | (m) | (m) | $630.10M | (m) |
| 2021-06-30 | (m) | (m) | $1.02M | $38.82M | (m) | (m) | $622.96M | (m) |
| 2021-03-31 | (m) | (m) | $5.08M | $16.57M | (m) | (m) | $598.39M | (m) |
| 2020-12-31 | (m) | (m) | $4.90M | $16.60M | (m) | (m) | $594.36M | (m) |
| 2020-09-30 | (m) | (m) | $5.00M | $7.51M | (m) | (m) | $575.44M | (m) |
| 2020-06-30 | (m) | (m) | $4.63M | $33.69M | (m) | (m) | $585.02M | (m) |
| 2020-03-31 | (m) | (m) | $728.00K | $118.60M | (m) | (m) | $643.25M | (m) |
| 2019-12-31 | (m) | (m) | $728.00K | $50.36M | (m) | (m) | $560.85M | (m) |
| 2019-09-30 | (m) | (m) | $718.00K | $55.29M | (m) | (m) | $565.19M | (m) |
| 2019-06-30 | (m) | (m) | $690.00K | $66.32M | (m) | (m) | $557.01M | (m) |
| 2019-03-31 | (m) | (m) | $1.07M | $29.52M | (m) | (m) | $523.09M | (m) |
| 2018-12-31 | (m) | (m) | $1.43M | $38.40M | (m) | (m) | $443.17M | (m) |
| 2018-09-30 | (m) | (m) | $4.77M | $54.66M | (m) | (m) | $454.97M | (m) |
| 2018-06-30 | (m) | (m) | $4.82M | $56.61M | (m) | (m) | $440.54M | (m) |
| 2018-03-31 | (m) | (m) | $5.32M | $42.78M | (m) | (m) | $417.62M | (m) |
| 2017-12-31 | (m) | (m) | $4.04M | $56.73M | (m) | (m) | $418.98M | (m) |
| 2017-09-30 | (m) | (m) | $2.75M | $59.95M | (m) | (m) | $410.99M | (m) |
| 2017-06-30 | (m) | (m) | $2.35M | $73.35M | (m) | (m) | $417.32M | (m) |
| 2017-03-31 | (m) | (m) | $1.22M | $62.80M | (m) | (m) | $387.67M | (m) |
| 2016-12-31 | (m) | (m) | $1.23M | $50.60M | (m) | (m) | $351.23M | (m) |
| 2016-09-30 | (m) | (m) | $986.00K | $40.55M | (m) | (m) | $309.90M | (m) |
| 2016-06-30 | (m) | (m) | $1.04M | $47.05M | (m) | (m) | $313.60M | (m) |
| 2016-03-31 | (m) | (m) | $1.25M | $57.12M | (m) | (m) | $311.43M | (m) |
| 2015-12-31 | (m) | (m) | $775.00K | $48.34M | (m) | (m) | $279.91M | (m) |
| 2015-09-30 | (m) | (m) | $1.41M | $47.68M | (m) | (m) | $276.14M | (m) |
| 2015-06-30 | (m) | (m) | $800.00K | $42.06M | (m) | (m) | $268.32M | (m) |
| 2015-03-31 | (m) | (m) | $932.00K | $41.98M | (m) | (m) | $257.42M | (m) |
| 2014-12-31 | (m) | (m) | $883.00K | $34.73M | (m) | (m) | $244.55M | (m) |
| 2014-09-30 | (m) | (m) | $850.00K | $46.95M | (m) | (m) | $247.74M | (m) |
| 2014-06-30 | (m) | (m) | $850.00K | $45.45M | (m) | (m) | $240.78M | (m) |
| 2014-03-31 | (m) | (m) | $775.00K | $45.95M | (m) | (m) | $228.63M | (m) |
| 2013-12-31 | (m) | (m) | $825.00K | $40.65M | (m) | (m) | $224.13M | (m) |
| 2013-09-30 | (m) | (m) | $575.00K | $14.55M | (m) | (m) | $179.66M | (m) |
| 2013-06-30 | (m) | (m) | $800.00K | $16.15M | (m) | (m) | $182.43M | (m) |
| 2013-03-31 | (m) | (m) | $659.00K | $20.73M | (m) | (m) | $176.88M | (m) |
| 2012-12-31 | (m) | (m) | $459.00K | $17.57M | (m) | (m) | $171.71M | (m) |
| 2012-09-30 | (m) | (m) | $609.00K | $16.27M | (m) | (m) | $169.94M | (m) |
| 2012-06-30 | (m) | (m) | $609.00K | $20.27M | (m) | (m) | $170.63M | (m) |
| 2012-03-31 | (m) | (m) | $483.00K | (m) | (m) | (m) | $164.44M | (m) |
| 2011-12-31 | (m) | (m) | $433.00K | (m) | (m) | (m) | $163.25M | (m) |
| 2011-09-30 | (m) | (m) | $533.00K | (m) | (m) | (m) | $164.04M | (m) |
| 2011-06-30 | (m) | (m) | $434.00K | (m) | (m) | (m) | $146.84M | (m) |
| 2010-12-31 | (m) | (m) | $250.00K | (m) | (m) | (m) | $140.86M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |